Hellman Jordan Management Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Hellman Jordan Management Company’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-35,045	Closed	-$3.41M	–	65
2018 Q4	$3.41M	Sell	35,045 -34,995	-50%	-$4.59M	3.82%	9
2018 Q3	$12.1M	Buy	+70,040	New	+$10.1M	8.71%	4

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hellman Jordan Management Company's GWPH Position: Q1 2019 in Review

Hellman Jordan Management Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 35,045 shares — an estimated $3.41M sold.

Hellman Jordan Management Company first reported a position in GWPH in Q3 2018 and held it in 2 quarters. The position peaked at $12.1M in Q3 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

Hellman Jordan Management Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Hellman Jordan Management Company sold 35,045 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $3.41M.
Hellman Jordan Management Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 2 quarters.
Hellman Jordan Management Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.1M in Q3 2018.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Hellman Jordan Management Company's 13F filing for Q1 2019, filed 11 Jun 2019.